MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
Clinical trials for MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS trials appear
Sign up with your email to follow new studies for MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare kidney disease patients through early access program
Disease control APPROVED_FOR_MARKETINGThis program provides early access to an investigational drug called pegcetacoplan for patients with rare kidney diseases C3G or IC-MPGN. It's for people aged 12+ who haven't responded well to other treatments and have active kidney disease. Participants must be able to self-admi…
Matched conditions: MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
European team hunts for better tests to spot rare kidney disease
Diagnosis OngoingThis study aims to create better tests to diagnose and monitor two rare, serious kidney diseases (aHUS and C3G). Researchers will analyze blood, cells, and tissue from about 180 patients and healthy people to find new markers of disease. The goal is to help doctors make faster, m…
Matched conditions: MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Diagnosis
Last updated Mar 20, 2026 14:48 UTC